Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral iron supplementation in critically ill anemic patients
NCT00450177Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jan 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ferrous sulfate in anemia, sponsored by Weill Cornell Medicine. Primary endpoints: Hematocrit at Day 28 and Serum Iron Concentration at Day 28. Started Jan 2006; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00450177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450177.